Posted: Tuesday, October 28, 2025
NCCN
(UPDATE) Ixazomib
Update Carfilzomib Kyprolis
CAR T-Cell Therapies: Idecabtagene Vicleucel and Ciltacabtagene Autoleucel
Selinexor